Literature DB >> 22072071

Non-contrast MRA using an inflow-enhanced, inversion recovery SSFP technique in pediatric abdominal imaging.

Suraj Serai1, Alexander J Towbin, Daniel J Podberesky.   

Abstract

Abdominal contrast-enhanced MR angiography (CE-MRA) is routinely performed in children. CE-MRA is challenging in children because of patient motion, difficulty in obtaining intravenous access, and the inability of young patients to perform a breath-hold during imaging. The combination of pediatric-specific difficulties in imaging and the safety concerns regarding the risk of gadolinium-based contrast agents in patients with impaired renal function has renewed interest in the use of non-contrast (NC) MRA techniques. At our institution, we have optimized 3-D NC-MRA techniques for abdominal imaging. The purpose of this work is to demonstrate the utility of an inflow-enhanced, inversion recovery balanced steady-state free precession-based (b-SSFP) NC-MRA technique.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072071     DOI: 10.1007/s00247-011-2275-0

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

Review 1.  Magnetic resonance angiography of the kidney.

Authors:  H B Marcos; P L Choyke
Journal:  Semin Nephrol       Date:  2000-09       Impact factor: 5.299

2.  Non-contrast renal artery MRA using an inflow inversion recovery steady state free precession technique (Inhance): comparison with 3D contrast-enhanced MRA.

Authors:  James F Glockner; Naoki Takahashi; Akira Kawashima; David A Woodrum; David W Stanley; Naoyuki Takei; Mitsuharu Miyoshi; Wei Sun
Journal:  J Magn Reson Imaging       Date:  2010-06       Impact factor: 4.813

3.  Steady-state free precession MRA of the renal arteries: breath-hold and navigator-gated techniques vs. CE-MRA.

Authors:  Jeffrey H Maki; Gregory J Wilson; William B Eubank; David J Glickerman; Sudhakar Pipavath; Romhild M Hoogeveen
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

4.  Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.

Authors:  S E Cowper; H S Robin; S M Steinberg; L D Su; S Gupta; P E LeBoit
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

5.  Pediatric cardiac-gated CT angiography: assessment of radiation dose.

Authors:  Caroline L Hollingsworth; Terry T Yoshizumi; Donald P Frush; Frandics P Chan; Greta Toncheva; Giao Nguyen; Carolyn R Lowry; Lynne M Hurwitz
Journal:  AJR Am J Roentgenol       Date:  2007-07       Impact factor: 3.959

6.  Pediatric body MR angiography.

Authors:  Rajesh Krishnamurthy; Raja Muthupillai; Taylor Chung
Journal:  Magn Reson Imaging Clin N Am       Date:  2009-02       Impact factor: 2.266

7.  Detection of main renal artery stenosis using phase-contrast cine MR angiography.

Authors:  J M Silverman; M L Friedman; R J Van Allan
Journal:  AJR Am J Roentgenol       Date:  1996-05       Impact factor: 3.959

8.  Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2006-10-24       Impact factor: 5.315

  8 in total
  3 in total

1.  Magnetic resonance urography and laparoscopy in paediatric urology: a case series.

Authors:  Maria Beatrice Damasio; Sara Costanzo; Emilio Podestà; Gianmarco Ghiggeri; Giorgio Piaggio; Fabio Faranda; Maria Ludovica Degl'Innocenti; Vincenzo Jasonni; Gian Michele Magnano; Piero Buffa; Giovanni Montobbio; Girolamo Mattioli
Journal:  Pediatr Radiol       Date:  2013-07-31

2.  Non-contrast-enhanced MRA of renal artery stenosis: validation against DSA in a porcine model.

Authors:  T A Bley; C J François; M L Schiebler; O Wieben; N Takei; J H Brittain; A Munoz Del Rio; T M Grist; S B Reeder
Journal:  Eur Radiol       Date:  2015-05-28       Impact factor: 5.315

3.  Feasibility of balanced steady-state free precession sequence at 1.5T for the evaluation of hepatic steatosis in obese children and adolescents.

Authors:  Hong-Xi Zhang; Jun-Fen Fu; Can Lai; Feng-Yu Tian; Xiao-Li Su; Ke Huang
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.